310 related articles for article (PubMed ID: 31621380)
1. Prognostic utility of the combination of pretreatment monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NMIBC after transurethral resection.
Wang Q; Huang T; Ji J; Wang H; Guo C; Sun X; Zheng K; Dong Z; Cao Y
Biomark Med; 2019 Dec; 13(18):1543-1555. PubMed ID: 31621380
[No Abstract] [Full Text] [Related]
2. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
Fan Z; Li Y; Ji H; Jian X
BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
[TBL] [Abstract][Full Text] [Related]
3. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
5. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
Chen H; Wu X; Wen Z; Zhu Y; Liao L; Yang J
Arch Esp Urol; 2022 Jun; 75(5):467-471. PubMed ID: 35983820
[TBL] [Abstract][Full Text] [Related]
6. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
[TBL] [Abstract][Full Text] [Related]
8. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
[No Abstract] [Full Text] [Related]
9. [Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].
Wang QH; Ji JL; Li H; He PL; Song LX; Zhao Y; Wang HY; Huang T; Sun XX; Cao YW; Dong Z; Shi BB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):622-629. PubMed ID: 31699192
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
[TBL] [Abstract][Full Text] [Related]
11. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization.
Luo F; Ma C; Wu J; Li J
Photobiomodul Photomed Laser Surg; 2019 May; 37(5):312-317. PubMed ID: 31084565
[No Abstract] [Full Text] [Related]
14. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD; Ferro M; Cantiello F; Lucarelli G; Di Stasi S; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdona S; Verze P; La Rocca R; Borghesi M; Schiavina R; Brunocilla E; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Battaglia M; Serretta V; Russo GI; Morgia G; Terracciano D; Musi G; de Cobelli O; Mirone V; Shariat SF
Clin Genitourin Cancer; 2018 Dec; 16(6):445-452. PubMed ID: 30077463
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
17. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G
Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence.
Zhao R; Shan J; Nie L; Yang X; Yuan Z; Xu H; Liu Z; Zhou X; Ma W; Shi H
J Clin Lab Anal; 2021 Aug; 35(8):e23883. PubMed ID: 34184796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
